rs2273913

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000559275.5(RNF31):​c.-272C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.223 in 1,614,022 control chromosomes in the GnomAD database, including 44,446 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.26 ( 5725 hom., cov: 33)
Exomes 𝑓: 0.22 ( 38721 hom. )

Consequence

RNF31
ENST00000559275.5 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -2.00

Publications

26 publications found
Variant links:
Genes affected
RNF31 (HGNC:16031): (ring finger protein 31) The protein encoded by this gene contains a RING finger, a motif present in a variety of functionally distinct proteins and known to be involved in protein-DNA and protein-protein interactions. The encoded protein is the E3 ubiquitin-protein ligase component of the linear ubiquitin chain assembly complex. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2015]
RNF31 Gene-Disease associations (from GenCC):
  • autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • immunodeficiency 115 with autoinflammation
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 14-24148029-C-T is Benign according to our data. Variant chr14-24148029-C-T is described in ClinVar as Benign. ClinVar VariationId is 1165355.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.527 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RNF31NM_017999.5 linkc.246C>T p.Tyr82Tyr synonymous_variant Exon 2 of 21 ENST00000324103.11 NP_060469.4
RNF31NM_001310332.2 linkc.-272C>T 5_prime_UTR_premature_start_codon_gain_variant Exon 2 of 21 NP_001297261.1
RNF31NM_001310332.2 linkc.-272C>T 5_prime_UTR_variant Exon 2 of 21 NP_001297261.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RNF31ENST00000324103.11 linkc.246C>T p.Tyr82Tyr synonymous_variant Exon 2 of 21 1 NM_017999.5 ENSP00000315112.6 Q96EP0-1
ENSG00000259529ENST00000558468.2 linkn.246C>T non_coding_transcript_exon_variant Exon 2 of 29 2 ENSP00000457512.2 A0A0B4J293

Frequencies

GnomAD3 genomes
AF:
0.258
AC:
39228
AN:
152032
Hom.:
5719
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.347
Gnomad AMI
AF:
0.0329
Gnomad AMR
AF:
0.218
Gnomad ASJ
AF:
0.0925
Gnomad EAS
AF:
0.545
Gnomad SAS
AF:
0.299
Gnomad FIN
AF:
0.226
Gnomad MID
AF:
0.108
Gnomad NFE
AF:
0.206
Gnomad OTH
AF:
0.232
GnomAD2 exomes
AF:
0.246
AC:
61317
AN:
249498
AF XY:
0.244
show subpopulations
Gnomad AFR exome
AF:
0.349
Gnomad AMR exome
AF:
0.218
Gnomad ASJ exome
AF:
0.0905
Gnomad EAS exome
AF:
0.545
Gnomad FIN exome
AF:
0.227
Gnomad NFE exome
AF:
0.198
Gnomad OTH exome
AF:
0.222
GnomAD4 exome
AF:
0.220
AC:
321408
AN:
1461872
Hom.:
38721
Cov.:
35
AF XY:
0.221
AC XY:
160884
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.351
AC:
11749
AN:
33480
American (AMR)
AF:
0.219
AC:
9785
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0898
AC:
2348
AN:
26136
East Asian (EAS)
AF:
0.533
AC:
21163
AN:
39700
South Asian (SAS)
AF:
0.286
AC:
24702
AN:
86258
European-Finnish (FIN)
AF:
0.224
AC:
11972
AN:
53412
Middle Eastern (MID)
AF:
0.135
AC:
776
AN:
5768
European-Non Finnish (NFE)
AF:
0.202
AC:
224924
AN:
1112002
Other (OTH)
AF:
0.232
AC:
13989
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
16698
33396
50094
66792
83490
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8100
16200
24300
32400
40500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.258
AC:
39247
AN:
152150
Hom.:
5725
Cov.:
33
AF XY:
0.260
AC XY:
19356
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.347
AC:
14408
AN:
41490
American (AMR)
AF:
0.218
AC:
3336
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0925
AC:
321
AN:
3472
East Asian (EAS)
AF:
0.544
AC:
2807
AN:
5160
South Asian (SAS)
AF:
0.297
AC:
1434
AN:
4828
European-Finnish (FIN)
AF:
0.226
AC:
2396
AN:
10584
Middle Eastern (MID)
AF:
0.112
AC:
33
AN:
294
European-Non Finnish (NFE)
AF:
0.206
AC:
13988
AN:
68000
Other (OTH)
AF:
0.234
AC:
494
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1448
2896
4345
5793
7241
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
408
816
1224
1632
2040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.217
Hom.:
6330
Bravo
AF:
0.260
Asia WGS
AF:
0.395
AC:
1374
AN:
3476
EpiCase
AF:
0.192
EpiControl
AF:
0.187

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 42% of patients studied by a panel of primary immunodeficiencies. Number of patients: 40. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
1.2
DANN
Benign
0.93
PhyloP100
-2.0
PromoterAI
0.33
Neutral
Mutation Taster
=299/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2273913; hg19: chr14-24617238; COSMIC: COSV53760109; COSMIC: COSV53760109; API